Acer Medical has recently launched its AI-assisted screening software, VeriSee Diabetic Retinopathy and VeriSee Age-Related Macular Degeneration.
These innovative solutions will be showcased at the Malaysian Ophthalmology Society (MSO) Annual Congress, bringing cutting-edge AI screening technology to Malaysia's ophthalmic community.
Acer Medical collaborates with hospitals and clinics in Malaysia to evaluate AI-driven medical solutions, enhancing diagnostic accuracy and efficiency.
The VeriSee AI ophthalmic screening software analyzes color fundus images within seconds, providing high-accuracy detection of diabetic retinopathy and age-related macular degeneration.
AI screening technology improves medical efficiency, enabling faster diagnoses at primary care facilities and ensuring timely treatment recommendations.
【MORE】